Russell NH, Wilhelm-Benartzi C, Othman J, Dillon R, et al. Fludarabine, Cytarabine, Granulocyte Colony-Stimulating Factor, and Idarubicin
With Gemtuzumab Ozogamicin Improves Event-Free Survival in Younger Patients With
Newly Diagnosed AML and Overall Survival in Patients With NPM1 and FLT3
Mutations. J Clin Oncol 2024;42:1158-1168.
PMID: 38215358